Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Chandra P. Belani"'
Publikováno v:
Anti-Cancer Drugs. 25:571-583
Taxanes are novel microtubule-stabilizing agents and have shown efficacy in non-small cell lung cancer (NSCLC) since the 1990s. Paclitaxel and docetaxel have been used either as single agents or in combination with a platinum compound. The newer gene
Autor:
Y, Yen, Dean W, Lim, Vincent, Chung, Robert J, Morgan, Lucille A, Leong, Stephen I, Shibata, Lawrence D, Wagman, Stephen D, Wagman, Howard, Marx, Peiguo G, Chu, Jeffrey A, Longmate, Heinz-Josef, Lenz, Ramesh K, Ramanathan, Chandra P, Belani, David R, Gandara
Publikováno v:
American Journal of Clinical Oncology. 31:317-322
Prolonged survival for patients with unresectable hepatocellular carcinoma (HCC) is consistently reported at lower than 6 months. Oxaliplatin has recently demonstrated activity in HCC. The objective of this study was to determine the response rate, s
Publikováno v:
Anti-Cancer Drugs. 10:S25-S28
The options for treating non-small cell lung cancer (NSCLC) were expanded by the introduction of the taxanes. As a single agent, docetaxel produced response rates ranging from 15 to 22% in evaluable patients in the second-line setting, with median du
Autor:
James D. Luketich, Robert J. Keenan, Ninh T. Nguyen, Chandra P. Belani, Tracey L Weigel, Peter F. Ferson
Publikováno v:
Surgical Laparoscopy, Endoscopy & Percutaneous Techniques. 9:171-175
Photodynamic therapy (PDT) was recently approved by the Food and Drug Administration for palliating obstructing esophageal cancer. This report reviews our initial experience using PDT to treat malignant dysphagia. Patients with inoperable, obstructin